CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding

Phase 2Neutral
AI Analysis

Summary

Vaxart announced it will present Phase IIb top-line data for its COVID-19 vaccine candidate in the first half of 2027, supported by BARDA funding.

Clinical Trial Data

Phase

IIb

Importance:5/10
Sentiment:
0.00
COVID-19Phase IIbBARDA fundingvaccine
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 8, 2026 1:44 AM

Read Original